Medical Research News and Research

RSS

NHMRC awards $2 million to investigate new therapies for reversing autoimmune disease

Research being undertaken at the University of Adelaide and Women's and Children's Hospital is providing vital clues into the causes of autoimmune diseases which affect millions of people around the world.

24 Oct 2011

FDA approves intraspinal injections in spinal cord stem cell ALS trial

Neuralstem, Inc. updated the progress of its ongoing Phase I safety trial of the company's spinal cord stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) at Emory University in Atlanta, Georgia.

24 Oct 2011

Social media moves into medicine

The Mayo Clinic's social media boss explains how the use of these high-tech tools has moved beyond marketing to find a place in medical education and research. Meanwhile, another news report showcases how doctors use email and Skype.

21 Oct 2011

University of Delaware receives DoD grant to create and manage BADER Consortium

The Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP) Peer Reviewed Orthopaedic Research Program (PRORP) has awarded a $19.7 million grant to the University of Delaware to create and manage a consortium that will improve the quality of life for warfighters who suffer significant limb injuries in combat.

20 Oct 2011

Tenofovir gel shows promise against HSV infection

HIV infection is commonly associated with other sexual infections, such as herpes simplex virus (HSV). Infection with HSV facilitates the risk of HIV infection and negatively impacts the clinical course of HIV disease. Therefore, it would be highly beneficial to identify multi-faceted microbicide compounds that are efficient against HIV-1 and other sexually transmitted infections.

20 Oct 2011

Viewpoints: CLASS decision ends fear of government bailout; the strengths and failings of U.S. health care

The problem, as numerous experts warned at the time, was whether the program could be run, as the law required, in a way that made it financially solvent for at least 75 years. The difficulty with the CLASS Act was ensuring that premiums could be set low enough to attract widespread participation but high enough to pay tbenefits. The risk was that the program would attract the sickest participants, who thought they might need its protections, and thereby drive premium prices ever higher in a spiral of dysfunctionhe promised.

19 Oct 2011

With clock ticking, super committee weighs suggestions, battles doubts

Last week the deficit-reduction panel received a slew of recommendations from across Capitol Hill on how to tame the nation's deficit problems. The input evidenced partisan differences and intra-party fissures. All the while, questions persist about the committee's ability to actually reach a deal.

18 Oct 2011

Commercialization strategies for next-generation medicines

The Center for Biotechnology at Stony Brook University, in collaboration with Demy-Colton Life Science Advisors, and key opinion leaders from the biotech and biopharmaceutical industries, academia, medical research foundations, and investment community, has organized a two-day event to forge partnerships to accelerate the development of new treatments for some of the world's most devastating diseases affecting millions.

18 Oct 2011

Stochastic frontier estimation can identify problem of bias in self-reporting

Most people are rather vague when reporting on food and drink consumption, smoking and exercise habits. General practitioners, however, are skilled at interpreting phrases such as "I only have a few drinks rarely...each week" and "I get to the gym regularly" and can estimate based on symptoms and a person's physical appearance just how precise those claims are. However, it is crucial for healthcare research and epidemiology that relies on patient self-reporting that we find a more objective, rather than intuitive, way to identify bias in self-reporting.

18 Oct 2011

New treatment approach for septic Listeria infection

Research underway at the Trudeau Institute could lead to new treatments for people sickened by Listeria and other sepsis-causing bacteria. Dr. Stephen Smiley's laboratory has published a study in the scientific journal Infection and Immunity that supports a new approach to treating these infections.

18 Oct 2011

Omega-3 in fish oil could reduce signs and symptoms of osteoarthritis

New research has shown for the first time that omega-3 in fish oil could "substantially and significantly" reduce the signs and symptoms of osteoarthritis.

18 Oct 2011

Brain tumour discovery offers drug treatment hope

Australian scientists have played a key role in the identification of a new biochemical mechanism that allows brain tumours to survive and grow, offering hope of new drug treatments for some of the most aggressive tumours.

17 Oct 2011

National award encourages bio-science student researchers

A key challenge for the bio-sciences sector is to keep its best research graduates in science and in Australia. The national student awards recognise and encourage promising research students and raise awareness of biosciences research translation and applications.

17 Oct 2011

NIH-funded study to evaluate rescue medications for victims of toxic gases

National Jewish Health researchers have received nearly $13 million from the National Institutes of Health to evaluate potential rescue medications for victims of terrorist attacks, wartime use of toxic gases, and/or inhalation disasters. The gases of greatest interest in these studies will be 'mustard gas' (sulfur mustard) and chlorine gas.

14 Oct 2011

Study: miR-34b gene associated with aggressive form of melanoma

A certain microRNA gene, miR-34b, could be a useful biomarker in early diagnosis of the most lethal forms of melanoma, according to new research published by KGI Professor Animesh Ray and his research collaborators.

14 Oct 2011

Action Medical Research announces grants to investigate conditions affecting babies, children

Action Medical Research - the leading UK-wide medical research charity dedicated to helping babies and children - has today announced grants worth more than £1.3 million for top researchers across the country.

13 Oct 2011

Skin cell to liver cell shows promise for genetic liver disease

In a new scientific breakthrough, researchers have taken skin cells from a patient with liver disease and turned them into replacement liver cells. Although the procedure is years before it can be used in humans, but if approved, it could launch a new era of personalized therapies for serious genetic disorders.

13 Oct 2011

Evidence suggests mosquitos in Kenya have developed chemical resistance, KEMRI official says

Speaking at a national malaria forum in Nairobi on Monday, Charles Mbogo of the Kenya Medical Research Institute (KEMRI) presented new evidence showing that malaria-causing mosquitos in Kenya have developed resistance to the most common chemicals derived from pyrethroids and DDT, which "could be a major blow to the country's strategy to eradicate malaria by 2017," Nigeria's the Nation reports.

12 Oct 2011

New information about effects of aging on the brain

Research by biologists at the University of York and Hull York Medical School has revealed important new information about the way the brain is affected by age.

11 Oct 2011

Australians urged to ‘Show Us Your Lungs!’

New research released today shows the extent to which Australians are ignoring their lung health, with results revealing that one in three people do not consider their lungs to be important even though 50 Australians die of lung disease each day.

10 Oct 2011